Skip to main content
close menu
close menu

Search UK HealthCare

Reese W. Randle, MD, FACS

| 4.82 out of 5
42 ratings | 14 comments
  • About

    Reese Randle is a board-certified general surgeon with additional fellowship training in endocrine surgery. He attended medical school at the University of Texas Health Science Center at Houston and completed his general surgery residency at Wake Forest University. Randle then received advanced training in endocrine surgery at the University of Wisconsin before joining the Endocrine Surgery Team at UK.

    Dr. Randle specializes in treating benign and malignant diseases of the thyroid, parathyroid and adrenal glands. He employs multiple operative techniques to enhance patient outcomes, including minimally invasive, radio-guided parathyroidectomy and laparoscopic and retroperitoneoscopic adrenalectomy. His research interests include improving the quality and efficiency of endocrine surgery, and improving the safety of surgical training.

    Dr. Randle is a member of the American Association of Endocrine Surgeons, the American Thyroid Association, the American College of Surgeons and the Association for Academic Surgery.

    Faculty Rank

    Assistant Professor of Surgery

    Degree

    McGovern Medical School at University of Texas at Houston

    Residency

    Wake Forest University, Bowman Gray School of Medicine, Winston-Salem, N.C.

    Fellowship

    Research Fellowship, Wake Forest University, Bowman Gray School of Medicine, Winston-Salem, N.C.

    Endocrine Surgery, University of Wisconsin, School of Medicine and Public Health, Madison

    Certifications and Special Training

    American Board of Surgery

    American College of Surgeons Thyroid and Parathyroid Ultrasound

  • Publications

    Publications

    1. Risk of Recurrence in Differentiated Thyroid Cancer: A Population-Based Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems. Gan T, Huang B, Chen Q, Sinner HF, Lee CY, Sloan DA, Randle RW. Annals of Surgical Oncology. 2019 Mar. [Epub ahead of print]
    2. Should the duration of primary hyperparathyroidism impact guidelines for evaluation and treatment? Randle RW, Lee CY. Surgery. 2019 Jan;165(1):105-106
    3. Survival in Patients with Medullary Thyroid Cancer after less than the Recommended Initial Operation. Randle RW, Bates MF, Schneider DF, Sippel RS, Pitt SC. Journal of Surgical Oncology. 2018 May; 117(6):1211-16
    4. Back so soon? - Is early recurrence of Papillary Thyroid Cancer really just persistent disease? Bates MF, Randle RW, Schneider DF, Lamas MR, Long KL, Pitt SC, Sippel RS. Surgery. 2018 Jan; 163(1):118-23
    5. Implications of Implementing NIFTP terminology in the management of patients with Thyroid Tumors. Randle RW, Zeiger MA. Surgery. 2018 Jan; 163(1):66-67
    6. Impact of Potassium Iodide on Thyroidectomy for Graves’ disease: Implications for Safety and Operative Difficulty. Randle RW, Bates MF, Long KL, Pitt SC, Schneider DF, Sippel RS. Surgery. 2018 Jan; 163(1):68-72
    7. Machine Learning to Identify Multigland Disease in Primary Hyperparathyroidism. Imbus J, Randle RW, Pitt SC, Sippel RS, Schneider DF. Journal of Surgical Research. 2017 Nov; 219:173-179
    8. Papillary Thyroid Microcarcinoma: Decision-Making, Extent of Surgery, and Outcomes. Price AK, Randle RW, Schneider DF, Sippel RS, Pitt SC. Journal of Surgical Research. 2017 Oct; 218:237-245
    9. Assessing the Risk of Hypercalcemic Crisis in Patients with Primary Hyperparathyroidism. Lowell AJ, Bushman NM, Wang X, Mu Y, Pitt SC, Sippel RS, Schneider DF, Randle RW. Journal of Surgical Research. 2017 Sep; 217:252-257
    10. Papillary Thyroid Cancer: The Good and Bad of the “Good Cancer.” Randle RW, Bushman NM, Orne J, Balentine CJ, Wendt E, Saucke M, Pitt SC, Macdonald CL, Connor NP, Sippel RS. Thyroid. 2017 Jul; 27(7):902-907
    11. Trends in the Presentation, Treatment, and Survival of Patients with Medullary Thyroid Cancer over the past 30 Years. Randle RW, Balentine CJ, Leverson GE, Havlena JA, Sippel RS, Schneider DF, Pitt SC. Surgery. 2017 Jan; 161(1):137-146
    12. Selective versus Non-Selective Alpha-Blockade prior to Laparoscopic Adrenalectomy for Pheochromocytoma. Randle RW, Balentine CJ, Pitt SC, Schneider DF, Sippel RS. Annals of Surgical Oncology. 2017 Jan; 24(1):224-250
    13. Should Vitamin D Deficiency be Corrected before Parathyroidectomy? Randle RW, Balentine CJ, Wendt E, Schneider DF, Chen H, Sippel RS. Journal of Surgical Research. 2016 Jul; 204(1):94-100
    14. Clinical Outcomes for Neuroendocrine Tumors of the Duodenum and Ampulla of Vater: A Population-Based Study. Randle RW, Ahmed S, Newman NA, Clark CJ. Journal of Gastrointestinal Surgery. 2014 Feb; 18(2)354-62
    15. Oncolytic Vesicular Stomatitis Virus as a Treatment for Neuroendocrine Tumors. Randle RW, Northrup SA, Sirintrapun SJ, Lyles DS, Stewart JH. Surgery. 2013 Dec; 154(6):1323-30
  • Ratings & Reviews

    - Overall Provider Rating: 4.82 out of 5 · 42 ratings · 14 comments

    The star rating is a calculation based on feedback from our patients using our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more about our survey process. Responses are measured on a scale of 1 to 5 with 5 being the best score.

    April, 2019
    Well pleased with everyone.

    March, 2019
    I was satisfied.

    March, 2019
    I couldn't have been treated any better. I would recommend UK HealthCare to family and friends.

    February, 2019
    Excellent.

    January, 2019
    Everyone was very professional.